Fundies.
English

Segment disclosures

Company overview

티움바이오

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 18 retained observations 13 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-304477378396 KRW20260814Open filing evidence
2026-01-01 – 2026-06-307427755843 KRW20260814Open filing evidence
2026-01-01 – 2026-03-312950377447 KRW20260515Open filing evidence
2025-01-01 – 2025-12-3112288796652 KRW20260318Open filing evidence
2025-07-01 – 2025-09-303121038727 KRW20251114Open filing evidence
2025-01-01 – 2025-09-307840745390 KRW20251114Open filing evidence
2025-04-01 – 2025-06-302613329965 KRW20260814Open filing evidence
2025-01-01 – 2025-06-304719706663 KRW20260814Open filing evidence
2025-01-01 – 2025-03-312106376698 KRW20260515Open filing evidence
2024-01-01 – 2024-12-316792235001 KRW20260318Open filing evidence
2024-07-01 – 2024-09-301131770887 KRW20251114Open filing evidence
2024-01-01 – 2024-09-305309974123 KRW20251114Open filing evidence
2024-04-01 – 2024-06-302186471118 KRW20250814Open filing evidence
2024-01-01 – 2024-06-304178203236 KRW20250814Open filing evidence
2024-01-01 – 2024-03-311991732118 KRW20250515Open filing evidence
2023-01-01 – 2023-12-314898775191 KRW20260318Open filing evidence
2021-01-01 – 2021-03-310 KRW20210517Open filing evidence
2020-01-01 – 2020-03-310 KRW20210517Open filing evidence